Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES |
|---|---|
| Recipient Organization | University of Illinois At Chicago |
| Country | United States |
| Start Date | Apr 01, 2024 |
| End Date | Jan 31, 2028 |
| Duration | 1,400 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10872500 |
ABSTRACT Hepatocytes exhibit compartmental (zonated) functions along the sinusoid with as many as 50% of liver genes thought to be zonated. The initiation and progression of several diseases can show a zonated bias including drug-induced liver injury, non-alcoholic fatty liver disease, and hepatocellular carcinoma. The fetal liver is not
zonated and thus zonation begins after birth due to gradients of O2, hormones, nutritional stimuli, and non- parenchymal cell (NPC) secretions acting on common pathways. As complementary tools to live animal studies, in vitro hepatocyte +/- NPC cultures subjected to specific factor gradients within fluidic devices can enable a
more detailed understanding of the regulators and functional outcomes of zonation. However, previous in vitro platforms/studies have only been able to recapitulate limited features and an incomplete understanding of hepatic zonation. We have pioneered a droplet microfluidics platform for the high-throughput generation of
reproducibly-sized 3D extracellular matrix (ECM) microgels (
University of Illinois At Chicago
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant